SecurityAMBR / Amber Road, Inc. (02318Y108)
IndustryPrepackaged Software
Institutional Owners83
Institutional Shares21,971,144 - 81.92%
Common Shares Outstanding26,819,429 shares (as of 2016-09-30)
Institutional Value$ 194,458,000 USD

Institutional Stock Ownership and Shareholders

AMBR / Amber Road, Inc. Institutional Ownership

Amber Road, Inc. (NYSE:AMBR) has 83 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,971,144 shares. Largest shareholders include Gagnon Neil, Royce & Associates LLC, BlackRock Inc., Oaktop Capital Management II, L.P., Gagnon Securities Llc, Granahan Investment Management Inc/ma, Needham Investment Management Llc, Vanguard Group Inc, Cramer Rosenthal Mcglynn Llc, and Herald Investment Management Ltd.
Amber Road, Inc. (NYSE:AMBR) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-14 13F-HR PEAK6 Investments, L.P. Call 45,200 0 -100.00 402 0 -100.00
2018-08-14 13F-HR PEAK6 Investments, L.P. Put 5,500 0 -100.00 49 0 -100.00
2018-08-09 13F-HR Royce & Associates LLC 1,645,771 1,705,139 3.61 14,647 16,045 9.54
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 50,719 90,184 77.81 451 849 88.25
2018-08-08 13F-HR Spark Investment Management LLC 22,300 21,200 -4.93 198 199 0.51
2018-08-15 13F-HR GRANAHAN INVESTMENT MANAGEMENT INC/MA 1,183,112 1,137,778 -3.83 10,530 10,706 1.67
2018-07-31 13F-HR LOS ANGELES CAPITAL MANAGEMENT & EQUITY RESEARCH INC 11,688 11,688 0.00 104 110 5.77
2018-07-30 13F-HR DUPONT CAPITAL MANAGEMENT Corp 40,144 378
2018-08-07 13F-HR LEVIN CAPITAL STRATEGIES, L.P. 109,453 113,553 3.75 974 1,069 9.75
2018-08-10 13F-HR FEDERATED INVESTORS INC /PA/ 0 563 0 5
2017-02-10 13F-HR BlackRock Advisors LLC 5,962 6,450 8.19 58 59 1.72
2018-09-18 13F-HR/A NORTHERN TRUST CORP 201,558 241,764 19.95 1,794 2,275 26.81
2017-01-13 13F-HR MetLife Securities, Inc 140 140 0.00 1 1 0.00
2018-08-14 13F-HR D. E. Shaw & Co., Inc. 194,989 218,184 11.90 1,735 2,053 18.33
2018-08-14 13F-HR BOARDMAN BAY CAPITAL MANAGEMENT LLC 48,747 25,000 -48.71 434 235 -45.85
2018-08-10 13F-HR UNITED SERVICES AUTOMOBILE ASSOCIATION 83,373 51,391 -38.36 742 2,279 207.14
2018-08-14 13F-HR Wellington Management Group LLP 23,607 0 -100.00 210 0 -100.00
2017-02-10 13F-HR BlackRock Investment Management, LLC 74,084 74,084 0.00 715 673 -5.87
2018-07-19 13F-HR MYCIO WEALTH PARTNERS, LLC 21,718 21,718 0.00 193 204 5.70
2018-08-09 13F-HR OMERS ADMINISTRATION Corp 63,500 0 -100.00 565 0 -100.00
2018-08-10 13F-HR TIVERTON ASSET MANAGEMENT LLC 31,876 0 -100.00 284 0 -100.00
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 30,582 33,826 10.61 272 318 16.91
2018-08-09 13F-HR BlackRock Inc. 1,153,481 1,409,806 22.22 10,266 13,266 29.22
2018-08-14 13F-HR TEACHERS ADVISORS INC 39,496 39,496 0.00 352 372 5.68
2018-08-13 13F-HR PRUDENTIAL FINANCIAL INC 10,460 98
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 68,883 79,083 14.81 613 744 21.37
2018-08-13 13F-HR OXFORD ASSET MANAGEMENT 0 109,932 0 1,045
2018-08-13 13F-HR KING LUTHER CAPITAL MANAGEMENT CORP 37,000 37,000 0.00 329 348 5.78
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 265,178 416,421 57.03 2,559 3,781 47.75
2018-08-10 13F-HR Cortina Asset Management, LLC 564,867 554,730 -1.79 5,027 5,220 3.84
2017-02-13 SC 13G/A GAGNON NEIL 1,778,526 2,287,832 28.64
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 20,646 0 -100.00 184 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 2,016 2,512 24.60 15 22 46.67
2018-07-30 13F-HR Penbrook Management LLC 71,800 91,800 27.86 639 864 35.21
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 14,825 114
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 4,144 775 -81.30 36,882 7,293 -80.23
2018-08-14 13F-HR BARCLAYS PLC 8,905 6,685 -24.93 79 63 -20.25
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 1,500 1,500 0.00 13 14 7.69
2018-08-14 13F-HR CRAMER ROSENTHAL MCGLYNN LLC 1,035,727 928,912 -10.31 9,218 8,741 -5.17
2018-08-13 13F-HR Renaissance Technologies LLC 687,580 6,119
2018-08-10 13F-HR Legal & General Group Plc 3,221 3,221 0.00 29 30 3.45
2018-08-15 13F-HR Herald Investment Management Ltd 910,000 910,000 0.00 8,071 8,563 6.10
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 23,374 44,919 92.18 208 423 103.37
2018-08-14 13F-HR Invesco Ltd. 23,597 36,507 54.71 210 344 63.81
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 30,900 57,477 86.01 276 541 96.01
2018-08-06 13F-HR RHUMBLINE ADVISERS 17,230 21,440 24.43 153 202 32.03
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 171,446 191,071 11.45 1,525 1,797 17.84
2018-08-10 13F-HR Neuburgh Advisers LLC 4,144 0 -100.00 37 0 -100.00
2018-08-10 13F-HR Meadow Creek Investment Management LLC 8,806 0 -100.00 78 0 -100.00
2018-08-14 13F-HR Whetstone Capital Advisors, LLC 52,396 0 -100.00 466 0 -100.00
2018-08-14 13F-HR Entrustpermal Partners Offshore Lp 186,500 0 -100.00 1,660 0 -100.00
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 17,872 21,112 18.13 160 198 23.75
2018-08-14 13F-HR STATE STREET CORP 312,739 326,869 4.52 2,783 3,077 10.56
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 0 95,195 0 896
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 555,409 14,654 -97.36 4,943 138 -97.21
2018-08-14 13F-HR UBS Group AG 1,988 3,933 97.84 18 37 105.56
2018-08-10 13F-HR OPPENHEIMER & CO INC 438,593 246,688 -43.75 3,903 2,321 -40.53
2018-08-13 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 13,319 18,142 36.21 119 171 43.70
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 407 4
2018-08-02 13F-HR KORNITZER CAPITAL MANAGEMENT INC /KS 127,700 118,200 -7.44 1,137 1,112 -2.20
2018-08-09 13F-HR Gagnon Advisors, LLC 662,366 671,219 1.34 5,895 6,316 7.14
2018-08-03 13F-HR COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 63,801 16,645 -73.91 568 157 -72.36
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 67,100 67,100 0.00 597 631 5.70
2018-08-09 13F-HR GAGNON SECURITIES LLC 1,252,785 1,283,567 2.46 11,150 12,078 8.32
2018-08-14 13F-HR VANGUARD GROUP INC 933,481 1,034,537 10.83 8,308 9,735 17.18
2018-08-14 13F-HR Dynamic Technology Lab Private Ltd 13,566 0 -100.00 120 0 -100.00
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 12,821 15,259 19.02 114 144 26.32
2018-08-14 13F-HR KENNEDY CAPITAL MANAGEMENT, INC. 336,404 309,392 -8.03 2,994 2,911 -2.77
2018-08-14 13F-HR TWO SIGMA ADVISERS, LP 55,002 94,402 71.63 490 888 81.22
2018-04-18 13F-HR/A FNY Partners Fund LP 2,500 22
2018-07-31 13F-HR GILDER GAGNON HOWE & CO LLC 76,662 76,302 -0.47 682 718 5.28
2018-07-24 13F-HR MEEDER ASSET MANAGEMENT INC 91 101 10.99 1 950 94,900.00
2018-08-14 13F-HR ROYAL BANK OF CANADA 813 912 12.18 7 9 28.57
2018-08-15 13F-HR DISCIPLINED GROWTH INVESTORS INC /MN 342,070 341,945 -0.04 3,044 3,218 5.72
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 31,004 35,849 15.63 276 337 22.10
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 2,018 6,340 214.17 18 60 233.33
2017-02-10 13F-HR BlackRock Fund Advisors 493,969 568,721 15.13 4,767 5,164 8.33
2018-08-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 133,000 133,000 0.00 1,184 1,252 5.74
2018-08-14 13F-HR Divisar Capital Management LLC 582,620 679,960 16.71 5,185 6,398 23.39
2018-08-14 13F-HR DEUTSCHE BANK AG\ 154,167 260,891 69.23 1,371 2,454 78.99
2018-07-25 13F-HR NORTHPOINTE CAPITAL LLC 0 229,636 0 2,161
2018-08-14 13F-HR PANAGORA ASSET MANAGEMENT INC 73,325 93,561 27.60 653 880 34.76
2018-08-14 13F-HR Valeo Financial Advisors, Llc 611 611 0.00 5 5 0.00
2018-08-10 13F-HR CITIGROUP INC 2,512 9,006 258.52 22 85 286.36
2018-08-13 13F-HR Allianz Asset Management AG 379,808 378,781 -0.27 3,380 3,564 5.44
2018-08-13 13F-HR Glen Harbor Capital Management LLC 5,698 0 -100.00 51 0 -100.00
2018-08-13 13F-HR Elkfork Partners LLC 7,252 0 -100.00 65 0 -100.00
2018-05-11 13F-HR Delpha Capital Management, Llc 216 0 -100.00 2 0 -100.00
2018-08-14 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 25,600 241
2018-08-07 13F-HR IFP Advisors, Inc 8,000 75
2018-08-13 13F-HR NEEDHAM INVESTMENT MANAGEMENT LLC 1,106,850 1,106,850 0.00 9,851 10,416 5.74
2018-08-07 13F-HR Trexquant Investment LP 40,787 17,603 -56.84 363 166 -54.27
2018-07-20 13F-HR Oaktop Capital Management II, L.P. 1,398,791 1,398,791 0.00 12,449 13,163 5.74
2018-08-14 13F-HR MORGAN STANLEY 60,157 81,220 35.01 535 764 42.80
2018-08-06 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 12,670 13,440 6.08 113 126 11.50
2018-08-14 13F-HR TWO SIGMA INVESTMENTS LLC 17,877 117,547 557.53 159 1,106 595.60
2017-01-18 13F-HR WALL STREET ASSOCIATES 395,255 206,255 -47.82 3,814 1,873 -50.89
2018-08-14 13F-HR JP Morgan Chase & Co 4,038 103,611 2,465.90 36 975 2,608.33

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

Is Amber Road (AMBR) Stock Outpacing Its Computer and Technology Peers This Year?

2018-08-15 zacks
Investors focused on the Computer and Technology space have likely heard of Amber Road (AMBR - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Computer and Technology peers, we might be able to answer that question. (1-0)

Amber Road, Inc. (AMBR) CEO Jim Preuninger on Q2 2018 Results - Earnings Call Transcript

2018-08-12 seekingalpha
Good day, everyone and welcome to the Amber Road Second Quarter 2018 Earnings Conference Call. Today’s call is being recorded. At this time, I would like to turn the conference over to Kevin Brogan [ph]. Please go ahead, sir. (1-0)

Amber Road (AMBR) Reports Q2 Loss, Tops Revenue Estimates

2018-08-08 zacks
Amber Road (AMBR - Free Report) just came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items. (2-0)

Amber Road's (AMBR) CEO Jim Preuninger on Q1 2018 Results - Earnings Call Transcript

2018-05-12 seekingalpha
Good day, and welcome to the Amber Road First Quarter 2018 Earnings Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Staci Mortenson, Investor Relations. Please go ahead. (4-0)

The Collectionist, the new hotel disrupter in town

2018-04-30 theage.com.au
There is new hotel in the sector, The Collectionist, which is set to disrupt the industry with a new concept. (4-0)

CUSIP: 02318Y108